Workhorse gains on IRS approval, Rocket Pharmaceuticals up on alignment with FDA By

© Reuters.

After-Hours Stock Movers:

Workhorse Group Inc. (Nasdaq: WKHS) 32% HIGHER; announced that it has received IRS approval as a qualified manufacturer for the Commercial Clean Vehicle Credit as defined in 30D(d)(3) of the Internal Revenue Code. With this approval, Workhorse customers are eligible to receive up to a $40,000 credit for deliveries of all Workhorse vehicles in 2023 and beyond.

Rocket Pharmaceuticals, Inc. (NASDAQ:) 29% HIGHER; announced that alignment has been reached with the Food and Drug Administration (FDA) on the global Phase 2 pivotal trial of RP-A501 for Danon Disease. Danon Disease is a uniformly fatal inherited cardiomyopathy that leads to mortality in the majority of male patients at age ~20 and females at age ~40, and for which there are no approved curative or disease-modifying therapies. The disease affects an estimated 15,000 to 30,000 patients in the U.S. and Europe.

Squarespace, Inc. (SQSP) 2% LOWER; announced that General Atlantic intends to offer 5,000,000 shares of the Company’s Class A common stock in a secondary underwritten public offering.

Source link






Leave a Reply

Your email address will not be published. Required fields are marked *